Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194987 · ClinicalTrials.gov registry record · Phase 2
A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
A Phase 2 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 2
- Development phase
- 102
- Enrollment target
NCT00194987: Completed Phase 2 study, sponsored by Weill Medical College of Cornell University.
NCT00194987 is a Phase 2 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 102 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (23% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00194987, a Phase 2 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 102 participants
- Enrollment target
Study Summary
The purposes of this study are to provide medical management by giving treatment to the mother that will bring up the fetal platelet count and to minimize the number of invasive procedures to the fetus (which may result in serious fetal injuries).
Primary Outcome
this uses the birth platelet count of the fetuses from the study when they are born
Interventions
- DRUG prednisone
- DRUG IVIG (Intravenous Immunoglobulin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2001-04 |
| Est. Completion | 2015-06-30 |
| Phase | Phase 2 |
What the finished NCT00194987 record still lists
NCT00194987 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (23% lower).
The record links to 0 conditions, and to 2 interventions - of which prednisone is the first listed.
NCT00194987 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00194987 about?
NCT00194987 is a clinical study titled "A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia". The purposes of this study are to provide medical management by giving treatment to the mother that will bring up the fetal platelet count and to minimize the number of invasive procedures to the fetus (which may result in serious fetal injuries).
What is the current status of trial NCT00194987?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 102 participants. The study started on 2001-04. Estimated completion is 2015-06-30.
What interventions are being tested in trial NCT00194987?
The interventions under investigation include: prednisone (DRUG), IVIG (Intravenous Immunoglobulin) (DRUG).
Who is sponsoring clinical trial NCT00194987?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00194987's enrollment target sits among peer trials
102 668th of 2000 higher than 1,329 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia